O'Brien, J.R. : Effects of salicylates on human platelets. Lancet1: No. 7546, 779 (April 13) 1968.
2.
Yussef, A.H. , and Barkhan, P.: Aspirin branches out as anti-clot agent. Ref., Med. World News, 16C, Oct. 3, 1969 (Brit. Med. J., Vol. 3, No. 5667).
3.
Gast, L.F.: Influence of aspirin on haemostatic parameters. Ann. Rheum. Dis., 23: 500 (Nov.) 1964.
4.
Evans, G., et al: The effect of acetylsalicylic acid on platelet function. J. Exp. Med., 128: 877 (Nov. 1) 1968.
5.
Frenkel, E.P. , et al: Fecal blood loss following aspirin and coated aspirin microspherule administration. J. Clin. Pharmacol. , 8: 347, 1968.
6.
Pierson, R.N. , et al: Aspirin and gastrointestinal bleeding . Amer. J. Med., 31: 259, 1961.
7.
Scott, J.T., et al: Studies of gastrointestinal bleeding caused by corticosteroids, salicylates, and other analgesics. Quart. J. Med., 30: 167 (April) 1961.
8.
Stubbé, L., et al: Aspirin preparations and their noxious effect on the gastrointestinal tract. Brit. Med. J., 1: 675, 1962.
9.
Kaneshiro, M.M. , et al: Bleeding time after aspirin in disorders of intrinsic clotting. New Eng. J. Med., 281: 1039 (Nov. 6) 1969.
10.
Chandler, A.B. : In vitro thrombotic coagulation of the blood . Lab. Invest., 7: 110 (March-April) 1958.
11.
Engelberg, H.: Cigarette smoking and the in vitro thrombosis of human blood. J.A.M.A., 193: 1933 (Sept.) 1965.
12.
Engelberg, H., and Engelberg, L.P.: The effect of cigarette smoking on various clotting time tests. Vascular Diseases.5: 226 (Dec.) 1968.
13.
Pool, J.C.F. , and French, J.E.: Thrombosis. J. Atherosclerosis Res., 1: 251, 1961.
14.
Rozenberg, M.C.: Blood viscosity and thrombosis in vitro in patients with previous myocardial infarction. Angiology . 19: 527 (Oct.) 1968.
15.
Hoak, J.C., et al: The antithrombotic effects of sodium heparin and sodium warfarin . Arch. Intern. Med., 117: 25 (Jan.) 1966.
16.
Yochem, D.E. : Thrombotic coagulation time: Description of a precise method of determination. Ohio State Med. J., 64: 1268 (Nov.) 1968.
17.
Didisheim, P., et al: Inhibition of arterial thrombosis and platelet adhesiveness in the rat by intravenous 2,4,6-Trimorpholinopyrimido-[5,4-d]-pyrimidine (RA 433). Mayo Clinic Proc., 45: 51 (Jan.) 1970.
Alexander, B. , and Wessler, S.: A Guide to Anticoagulant Therapy, p. 22. Amer. Heart Assoc., 1961.
20.
Douthwaite, A.H. , and Lintott, G.A.M.: Gastroscopic observations of the effect of aspirin and certain other substances on the stomach. Lancet2: 1222 (Nov. 26) 1938.
21.
Thorsen, W.B. , Jr., et al: Aspirin injury to the gastric mucosa . Arch. Intern. Med., 121: 499 (June) 1968.
22.
Editorial: Aspirin and gastrointestinal bleeding. J.A.M.A., 207: 2430 (March) 1969.
23.
Fitzgerald, D.E. , and Butterfield, W.J.H.: A case of increased platelet anti-heparin factor in a patient with Raynaud's phenomena and gangrene, treated by aspirin . Angiology. 20: 317 (June) 1969.